Healthcare / Health Plans · Clinical Quality & Patient Safetyprovider

Harm Surveillance & Trigger Review

Transforms⟳In Flux

Near-term

Proven but early — expect one to three years to mainstream.

Readiness: Now — Deployable with established commercial tools today · Near-term — Proven but early — expect one to three years to mainstream · Emerging — Demonstrated, not yet production-mainstream

Readiness reflects an editorial assessment against a published rubric as of August 2026 — an observation about current tool maturity and adoption, not a prediction about specific products or timelines.

Trajectories describe the observable direction of human effort — not a prediction about specific roles, headcount, or individual careers.

What You Do Today

You know the incident reports are not the whole picture, so you go looking for harm in the chart instead. A sample of records is screened against a list of triggers: a reversal agent given, an unplanned transfer to a higher level of care, an unexpected return to the operating room, a medication stopped abruptly, a transfusion nobody anticipated, a positive culture that appeared days into the stay. A trigger is not a finding. It is a reason to read the record. Reviewers read the flagged charts, a second confirms, and together they decide whether harm actually occurred and how severe it was. It is slow, so you sample rather than screen everything, which means your harm rate is an estimate drawn from a sampled subset of admissions and can move for reasons that are really sampling. Alongside it you carry the harm that gets counted whether or not anyone reports it: infections submitted through national surveillance, the safety indicators that fall out of coded claims, the conditions flagged as not present on admission.

AI Technologies

Roles Involved

Who works on this

Chief Nursing OfficerChief Medical OfficerVP of Clinical OperationsDirector of Clinical OperationsNurse

C-SuiteVP/SVPDirectorIndividual Contributor

How It Works

Trigger rules run against the structured record continuously rather than against a pulled sample: medication administration, laboratory results, orders, transfers, procedures, coded diagnoses. Clinical NLP extends the same search into the parts of the record that were never structured, which is where harm is usually described rather than coded: the progress note recording a reaction, the operative note describing an unplanned repair, the nursing note saying what was done when the patient dropped. When a trigger fires, case assembly builds a reviewable timeline instead of handing over a chart number, so the reviewer opens what was given, what changed and what was done about it, in the order it happened. Ranking puts the cases most likely to represent real harm in front of reviewers first, so screening stops consuming the capacity that reviewing needs. The same infrastructure feeds the counts that are already mandatory: surveillance definitions applied to microbiology results and device-day denominators, and the safety indicators derived from coded claims with present-on-admission flags.

What Changes

Screening can cover every admission rather than a sample, so the harm rate stops being an estimate drawn from a sampled subset of records. Detection moves closer to the event, which means a case can be reviewed while the people involved still remember it rather than long afterward. Reviewer time shifts from finding candidate charts to reading them. Harm that never entered the reporting queue at all becomes visible to the department.

What Stays the Same

A trigger is not harm and never has been. Whether the patient was harmed, whether the harm was preventable, and whether care caused it or the disease did are clinical determinations that experienced reviewers disagree about for real reasons, and a model trained on their decisions reproduces that disagreement rather than resolving it. Comparing harm rates across the switch-on is a trap the method sets: finding more because you looked harder is not the same as harm increasing, and a leader who reads the new number as a decline in safety will make the wrong decision with it. What the organization does with harm it has found that nobody reported is a governance question with legal weight, covering what is disclosed to the patient, what is owed to the state, and what is protected as patient safety work product. That belongs to risk management, counsel and the clinicians involved, not to the detection layer. Surveillance also inherits the biases of the record it reads: harm to patients whose care is documented less thoroughly is detected less often, which is the opposite of who most needs finding. Telling the patient stays human, and stays hard.

Cross-Industry Concepts

anomaly detection surveillance sampling

Evidence & Sources

•IHI Global Trigger Tool for Measuring Adverse Events
•AHRQ Quality Indicators, Patient Safety Indicators
•CDC National Healthcare Safety Network healthcare-associated infection surveillance definitions
•CMS Hospital-Acquired Condition Reduction Program
•HHS Office of Inspector General, Hospital Incident Reporting Systems Do Not Capture Most Patient Harm (2012)
•CMS Conditions of Participation, Quality Assessment and Performance Improvement (42 CFR 482.21)

Sources listed are directional references, not formal citations. Verify against primary sources before using in business cases or presentations.

Last reviewed: August 2026

What To Do Next

This section won't tell you what your numbers should be. It will show you how to find them yourself. Every instruction below produces a real, verifiable result in your organization. No benchmarks, no projections — just the steps to build your own evidence.

Establish Your Baseline

Know where you are before you move

Before adopting AI tools for harm surveillance & trigger review, document your current state in utilization management.

•

Map your current process: Document how harm surveillance & trigger review works today — who does what, how long each step takes, and where the bottlenecks are. Use your safety event reporting system data to establish a factual baseline.

•

Identify the judgment calls: A trigger is a reason to look at the chart, not a finding. Whether harm occurred is a clinical judgment made by people, in review. — these are the boundaries AI won't cross. Know them before you start.

•

Check your data readiness: AI tools for utilization management need clean, accessible data. Check whether your safety event reporting system has the historical data, integrations, and quality to support ML Predicted LOS tools.

Without a baseline, you can't tell whether AI actually improved harm surveillance & trigger review or just changed who does it.

Define Your Measures

What to track and how to calculate it

patient outcomes

How to calculate

Measure patient outcomes for harm surveillance & trigger review before and after AI adoption. Pull from your safety event reporting system.

Why it matters

This is the most direct indicator of whether AI is adding value to utilization management.

clinical documentation quality

How to calculate

Track clinical documentation quality using the same methodology you use today. Don't change how you measure just because you changed how you work.

Why it matters

Speed without quality is just faster mistakes. Measure both together.

When to check: Check after 30 days of consistent use, then quarterly.

The commitment: Give new tools at least 30 days before judging. The first week is always awkward.

What NOT to measure: Don't measure AI adoption rate as a goal. Measure outcomes. If the tool helps with harm surveillance & trigger review, people will use it.